Walleye Capital’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.6K Sell
4,279
-7,721
-64% -$24K ﹤0.01% 4444
2026
Q1
$27.4K Sell
12,000
-596,231
-98% -$1.37M ﹤0.01% 4026
2025
Q4
$1.7M Buy
608,231
+192,880
+46% +$689K 0.01% 1999
2025
Q3
$1.99M Buy
415,351
+220,896
+114% +$1.41M 0.01% 1578
2025
Q2
$1.77M Sell
194,455
-71,793
-27% -$529K 0.01% 1613
2025
Q1
$2.4M Buy
+266,248
New +$2.81M 0.01% 1288
2024
Q2
Sell
-9,977
Closed -$204K 5881
2024
Q1
$276K Buy
+9,977
New +$222K ﹤0.01% 3724
2023
Q3
Sell
-3,790
Closed -$72.2K 5194
2023
Q2
$72.2K Sell
3,790
-7,060
-65% -$126K ﹤0.01% 3528
2023
Q1
$158K Buy
+10,850
New +$194K ﹤0.01% 2653
2020
Q4
Sell
-8,013
Closed -$201K 1065
2020
Q3
$201K Sell
8,013
-7,415
-48% -$108K 0.02% 614
2020
Q2
$118K Buy
+15,428
New +$113K 0.03% 497
2019
Q4
Sell
-29,400
Closed -$171K 2134
2019
Q3
$171K Sell
29,400
-3,200
-10% -$14.4K 0.01% 1259
2019
Q2
$104K Buy
+32,600
New +$111K 0.01% 1212

Other funds holding ACH

Walleye Capital's ACH Position: Q2 2026 in Review

Walleye Capital reduced its Accendra Health (ACH) stake by 64% in Q2 2026, selling an estimated $24K and leaving 4,279 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4444.

Walleye Capital first reported a position in ACH in Q2 2019 and has held it in 13 quarters since. The position peaked at $2.4M in Q1 2025. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Walleye Capital held 4,279 shares of Accendra Health worth $14.6K as of Q2 2026.
  • Walleye Capital sold 7,721 Accendra Health shares in Q2 2026, an estimated $24K.
  • Accendra Health made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4444 holding.
  • Walleye Capital first reported a position in Accendra Health in Q2 2019 and has held it in 13 quarters since.
  • Walleye Capital's Accendra Health position peaked at $2.4M in Q1 2025.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.